SPOTLIGHT -
The Outlook for JAK Inhibitors in Myelofibrosis
Ayalew Tefferi, MD, hematologist, Mayo Clinic, Rochester, Minnesota, discusses the outlook for JAK inhibitors for patients with myelofibrosis.
